Healthtech Startups

Practice Better is a business management platform for health and wellness practitioners, including nutritionists and similar independent professionals, that handles scheduling, billing, and client management to reduce administrative overhead and support business growth.

2 investors

Precigen is a biopharmaceutical company developing gene and cell therapies, including PAPZIMEOS (zopapogene imadenovec-drba), an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis. The company focuses on immuno-oncology and immunotherapy treatments delivered via subcutaneous injection.

2 investors

PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.

2 investors

Predictably Human is developing NoMore, an adaptive drug delivery device paired with a personalized digital companion, aimed at patients with mental health conditions, addiction, and other complex disorders. The system is intended to support an ecosystem of digital products and services around treatment.

2 investors

Predoc is an AI-native medical records platform that retrieves patient records from health information exchanges and non-connected providers, then normalizes and delivers complete longitudinal patient histories into existing clinical workflows. It serves healthcare providers, clinical research teams, and care delivery organizations by integrating with EHRs and operational systems via API or file exports.

2 investors

Preferred Homecare provides in-home clinical services and durable medical equipment (DME), including wheelchairs and hospital beds, along with related therapies and products. It serves patients receiving care at home through trained professionals and clinicians.

2 investors

PregnanTech develops a silicone medical device placed around the uterine cervix to help keep the cervix elongated, addressing preterm birth. The device is inserted by a physician as a short outpatient procedure.

2 investors

Prelude Therapeutics is a precision oncology company developing cancer treatments for areas of high unmet need, with a pipeline including selective KAT6A degraders and mutant-selective JAK2V617F JH2 inhibitors. It also applies targeted protein degradation expertise to develop next-generation degrader antibody conjugates (DACs).

2 investors

PreludeDx develops precision diagnostic tests for breast cancer to help physicians make informed treatment decisions and improve patient outcomes. The company serves oncologists, breast surgeons, and pathologists requiring molecular diagnostics for DCIS and other breast cancer subtypes.

2 investors

Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment. Its initial clinical targets are women at elevated risk of ovarian cancer and people with indeterminate lung nodules.

2 investors

Prescribe FIT offers a remote patient monitoring and virtual lifestyle health coaching platform focused on musculoskeletal (MSK) conditions, helping patients address lifestyle-related root causes to improve surgical and non-surgical outcomes. It serves orthopedic clinics and their patients, providing care coordination, insurance eligibility checks, and at-home coaching.

2 investors

Press Ganey provides software platforms, data analytics, and consulting services to healthcare organizations to measure and improve patient experience, caregiver engagement, and care quality. The company serves healthcare providers, health plans, and health systems across the United States.

2 investors

PrettyLitter is a veterinarian-developed cat litter with color-changing crystals that monitor a cat's urine pH and detect signs of illness while controlling odor. It is sold direct to cat owners through flexible subscription plans or one-time purchases.

2 investors

Prevenotics develops AI-based medical diagnostic software focused on gastrointestinal cancer, aimed at improving diagnostic accuracy and identifying pre-cancerous risks to support preventive diagnosis. Its technology targets high-risk groups and seeks to reduce unnecessary biopsies for upper-GI cancer.

2 investors

PREVENT provides health support services targeting high-risk populations with lifestyle-related diseases, with a focus on preventing disease progression and supporting patients' return to daily life. The company expands its expertise across diverse health issues and workplace health management challenges.

2 investors

Preventive.bio focuses on preventing disease before birth. The page provides no further detail about its products, technology, or customers.

2 investors

Previvor Edge offers a multidisciplinary cancer prevention and early-detection program that combines genetic testing, clinical risk assessment, lifestyle guidance, and screening tools such as multi-cancer tests and full-body MRIs. It serves individuals at elevated cancer risk, including those with a family history, and works with multiple insurance plans as well as self-pay options.

2 investors

Primaa develops AI services for computational pathology, building deep learning models that support pathologists in cancer diagnosis. The company's technology assists medical professionals with digital pathology and diagnostic accuracy, with a focus on areas such as breast pathology.

2 investors

PrimaKu operates a healthcare ecosystem in Indonesia connecting parents, pediatricians, and clinics, with apps for child growth monitoring, immunization tracking, and teleconsultations. It also provides an electronic medical record system for clinics and integrates with Satusehat, Indonesia's national medical registry.

2 investors

Prime Discoveries develops multiplex PCR diagnostic panels that detect pathogens and antimicrobial-resistance genes across areas such as respiratory infection, sepsis, gastrointestinal illness, STIs, tropical fevers, and biosurveillance. Its panels serve clinical diagnostics, hospital infection control, public-health surveillance, pharmaceutical QC, and biodefense applications.

2 investors

Primo Capital is an Italian independent alternative investments platform managing funds focused on climate, health, digital, and space technology sectors. It invests in early- and growth-stage startups, with 507M in committed capital across four investment strategies and a portfolio of 66 companies.

2 investors

Pristyn Care operates a network of clinics across India offering various medical specialities including proctology, laparoscopy, gynaecology, ENT, urology, and other surgical and medical services. The company provides healthcare services to patients seeking specialized medical treatment at multiple clinic locations throughout the country.

2 investors

Proclaim manufactures a customized oral health device that uses water pulsation to clean teeth and gums; it partners with dental professionals to create personalized mouthpieces via 3D scanning for individual users.

2 investors

Profility provides an AI-powered platform that automates the creation and management of prior authorizations for patients in skilled nursing and home health settings. The platform integrates with electronic medical records and analyzes managed care contracts to help case managers and healthcare providers streamline authorization workflows.

2 investors